Hemostemix HMTXF Stock
Hemostemix Price Chart
Hemostemix HMTXF Financial and Trading Overview
| Hemostemix stock price | 0.04 USD |
| Previous Close | 0.08 USD |
| Open | 0.08 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.08 - 0.08 USD |
| 52 Week Range | 0.08 - 0.29 USD |
| Volume | 77 USD |
| Avg. Volume | 3.04K USD |
| Market Cap | 7.6M USD |
| Beta (5Y Monthly) | 0.653198 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HMTXF Valuation Measures
| Enterprise Value | 10.25M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.806 |
Trading Information
Hemostemix Stock Price History
| Beta (5Y Monthly) | 0.653198 |
| 52-Week Change | -63.59% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.29 USD |
| 52 Week Low | 0.08 USD |
| 50-Day Moving Average | 0.11 USD |
| 200-Day Moving Average | 0.13 USD |
HMTXF Share Statistics
| Avg. Volume (3 month) | 3.04K USD |
| Avg. Daily Volume (10-Days) | 3.17K USD |
| Shares Outstanding | 81.09M |
| Float | 69.57M |
| Short Ratio | N/A |
| % Held by Insiders | 11.75% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -246.65% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -3651019 USD |
| Net Income Avi to Common (ttm) | -4876430 USD |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 272.34K USD |
| Total Cash Per Share (mrq) | 0.003 USD |
| Total Debt (mrq) | 4.02M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.163 |
| Book Value Per Share (mrq) | -0.086 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6398746 USD |
| Levered Free Cash Flow (ttm) | -4811998 USD |
Profile of Hemostemix
| Country | United States |
| State | AB |
| City | Calgary |
| Address | 707-7th Avenue SW |
| ZIP | T2P 3H6 |
| Phone | N/A |
| Website | https://hemostemix.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia in Canada and the United States. The company is also developing various types of cell products, such as synergetic cell populations, neural cell precursors, and cardiomyocyte cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.
Q&A For Hemostemix Stock
What is a current HMTXF stock price?
Hemostemix HMTXF stock price today per share is 0.04 USD.
How to purchase Hemostemix stock?
You can buy HMTXF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hemostemix?
The stock symbol or ticker of Hemostemix is HMTXF.
Which industry does the Hemostemix company belong to?
The Hemostemix industry is Biotechnology.
How many shares does Hemostemix have in circulation?
The max supply of Hemostemix shares is 97.25M.
What is Hemostemix Price to Earnings Ratio (PE Ratio)?
Hemostemix PE Ratio is now.
What was Hemostemix earnings per share over the trailing 12 months (TTM)?
Hemostemix EPS is -0.03 USD over the trailing 12 months.
Which sector does the Hemostemix company belong to?
The Hemostemix sector is Healthcare.